⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ABEO News
Abeona Therapeutics Inc. Common Stock
Abeona Therapeutics® Announces Appointment of Mohamad Tabrizi as Chief Business Officer
globenewswire.com
ABEO
NKTX
Abeona Therapeutics® Announces New Qualified Treatment Center for ZEVASKYN® in Texas
globenewswire.com
ABEO
Abeona Therapeutics® Announces First Patient Treatment with ZEVASKYN® Gene Therapy
globenewswire.com
ABEO
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
ABEO
Abeona Therapeutics® Reports Third Quarter 2025 Financial Results and Corporate Updates
globenewswire.com
ABEO
Abeona Therapeutics® Announces Date of Third Quarter Financial Results and Upcoming Investor Conference Participation
globenewswire.com
ABEO
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
ABEO
Abeona Therapeutics® Announces Permanent J-Code for ZEVASKYN® (prademagene zamikeracel)
globenewswire.com
ABEO
Abeona Therapeutics® Announces ABO-503 Gene Therapy for X-linked Retinoschisis (XLRS) Selected by FDA for Rare Disease Endpoint Advancement (RDEA) Pilot Program
globenewswire.com
ABEO
Abeona Therapeutics® and Children's Hospital Colorado Announce Newest Treatment Center for ZEVASKYN® Gene Therapy
globenewswire.com
ABEO